Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Neuroblastoma”

311 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 311 results

Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Not applicableAvailableNCT01590680
What this trial is testing

Expanded Access Protocol Using 131I-MIBG

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Jubilant DraxImage Inc.
Early research (Phase 1)Ended earlyNCT05429502
What this trial is testing

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Who this might be right for
Neuroblastoma
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT00206388
What this trial is testing

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement

Who this might be right for
NEUROBLASTOMA
Baylor College of Medicine 21
Not applicableStudy completedNCT01850888
What this trial is testing

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Who this might be right for
Relapsed NeuroblastomaMetastatic Pheochromocytoma
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Looking for participantsNCT06803875
What this trial is testing

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-risk Neuroblastoma
Roberto Chiarle 42
Early research (Phase 1)Study completedNCT00931931
What this trial is testing

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors

Who this might be right for
RhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more
Timothy Cripe 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00486564
What this trial is testing

Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
University of Vermont 20
Early research (Phase 1)Study completedNCT01576692
What this trial is testing

Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 34
Testing effectiveness (Phase 2)Looking for participantsNCT05027386
What this trial is testing

Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.

Who this might be right for
Neuroblastoma
Sun Yat-sen University 125
Early research (Phase 1)Study completedNCT02765243
What this trial is testing

Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma

Who this might be right for
NeuroblastomaEffects of Immunotherapy
Zhujiang Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Testing effectiveness (Phase 2)WithdrawnNCT02011126
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
HepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more
Children's Oncology Group
Early research (Phase 1)Study completedNCT00075634
What this trial is testing

Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

Who this might be right for
Recurrent NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT01704872
What this trial is testing

Ch14.18/CHO Bridging Study

Who this might be right for
Neuroblastoma
St. Anna Kinderkrebsforschung 16
Early research (Phase 1)Study completedNCT01059071
What this trial is testing

Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide

Who this might be right for
Neuroblastoma
Giselle Sholler 21
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Load More Results